STEERABLE GUIDE CATHETER SGC0302

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a company representative,foreig report with the FDA on 2020-03-20 for STEERABLE GUIDE CATHETER SGC0302 manufactured by Abbott Vascular.

Event Text Entries

[187406172] The device was not returned for analysis. A review of the lot history record revealed no manufacturing nonconformities issued to the reported lot. In this case, there was no reported device malfunction associated with the steerable guide catheter (sgc). The reported patient effect of tissue damage, as listed in the mitraclip system instructions for is a known possible complication associated with mitraclip procedures. The investigation was unable to determine a cause for the reported the reported tissue damage. There is no indication of a product issue with respect to manufacture, design or labeling. The first clip, cds0502 80817u122, mentioned is filed under a separate medwatch report.
Patient Sequence No: 1, Text Type: N, H10


[187406173] Patient id: (b)(6). This report is being filed due to possible device related tissue injury. It was reported that on (b)(6) 2018, the patient presented with ischemic functional mitral regurgitation (mr) grade 4+, and leaflet tethering. The steerable guide catheter (sgc) was placed without any unusual resistance. It was possible that septal tissue possibly attached to the sgc. Mitraclip, cds0502 80817u122, advanced to the left atrium, without any unusual resistance, when septal tissue on the clip was observed. The clip as removed without reported issues and not implanted. Reportedly, it is unknown if the clip, cds0502 80817u122, or the sgc damaged the tissue. Another mitraclip (cds0502 80810u133) was implanted without a device issue, reducing the mr to grade 2+. On (b)(6) 2018, a follow-up echocardiogram was performed and the mr was graded 3+. Per physician, the increase in mr was due to disease progression. There was no device issue. The implanted clip (cds0502 80810u133) had remained stable and well seated without tissue injury. On (b)(6) 2019, the patient was hospitalized for a worsening of their pre-existing heart failure. Medications were provided. During this hospitalization and on (b)(6) 2019, the patient expired due to heart failure. Per physician, the events were unrelated to the mitraclip device and unrelated to the mitraclip procedure. There was no device malfunction. No additional information was provided regarding this issue.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number2024168-2020-02715
MDR Report Key9860916
Report SourceCOMPANY REPRESENTATIVE,FOREIG
Date Received2020-03-20
Date of Report2020-03-20
Date of Event2018-11-09
Date Mfgr Received2020-02-26
Device Manufacturer Date2018-07-23
Date Added to Maude2020-03-20
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMS. LINDSEY BELL
Manufacturer Street26531 YNEZ RD.
Manufacturer CityTEMECULA CA 925914628
Manufacturer CountryUS
Manufacturer Postal925914628
Manufacturer Phone9519143996
Manufacturer G1ABBOTT VASCULAR, REG # 3005070406
Manufacturer Street3885 BOHANNON DRIVE
Manufacturer CityMENLO PARK CA 94025
Manufacturer CountryUS
Manufacturer Postal Code94025
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameSTEERABLE GUIDE CATHETER
Generic NameVALVE REPAIR
Product CodeDRA
Date Received2020-03-20
Catalog NumberSGC0302
Lot Number80723U124
Device Expiration Date2019-07-23
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerABBOTT VASCULAR
Manufacturer Address26531 YNEZ RD. TEMECULA CA 925914628 US 925914628


Patients

Patient NumberTreatmentOutcomeDate
101. Other 2020-03-20

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.